Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,528.52
(
2.91%
)
US TECH 100
23,078.06
(
3.34%
)
Dow Jones
46,341.51
(
2.49%
)
Brent Oil
103.28
(
-4.87%
)
Bitcoin
67,999.80
(
1.95%
)
News Focus
News Focus
Post# of 257322
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

randychub

Send PM Follow Ignore
Followers 24
Posts 2706
Boards Moderated 0
Alias Born 10/23/2003

randychub

Re: poorgradstudent post# 5299

Wednesday, 12/01/2004 10:23:20 PM

Wednesday, December 01, 2004 10:23:20 PM

Post# of 257322
BMY dropped the drug after they did not get good data on TTP. YMI picked it up after the ASCO abstract that showed the drug extended life by 50%. After breaking the data down into 3 groups, mets in 0-6 months, mets 6-36 months, and 36 months and over they found that the first 2 groups did very well and the last group seen no benifit.

THanks for you thoughts.

Randy
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today